Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
START Los Angeles, Los Angeles, California Astera Cancer Care, East Brunswick, New Jersey Sarah Cannon and HCA Research Institute, Nashville, Tennessee MD Anderson Cancer Center, Houston, Texas South Texas Accelerated Research Therapeutics (START), San Antonio, Texas